Can BPC-157 be combined with TB-500
Monthly 1-week protocols, or 8 weeks on/8 weeks off cycles maintaining benefits without continuous use
Patients report faster treatment starts, clearer pricing, and simplified monthly billing compared to insurance-dependent alternatives
Cardiovascular Studies Cardiac Protection Research has demonstrated BPC-157's potential cardioprotective effects [21]: Protection against arrhythmias induced by various drugs Improved cardiac function after ischemic injury Enhanced coronary blood flow Reduced infarct size in heart attack models Blood Vessel Effects Studies on blood vessel healing show BPC-157 promotes: Arterial healing after injury Venous healing and reduced thrombosis Collateral vessel development Endothelial function improvement Benefits by Category with Evidence Ratings Gut Healing Strong Evidence Evidence Rating: Strong (Multiple animal studies, consistent results) The gastrointestinal applications of BPC-157 have the most robust research support: Ulcer healing (gastric and duodenal) NSAID-induced damage protection and reversal Inflammatory bowel conditions Intestinal permeability ("leaky gut") Esophageal damage healing Liver protection The consistency of results across multiple studies and various injury models provides strong preclinical evidence
A licensed prescriber reviews your information and may follow up by text, email, or video, depending on your states requirements
In December 2024, the FDA gave Zepbound (tirzepatide) an additional approval to treat obstructive sleep apnea
